The tumor suppressive role of inhibin βA in diffuse large B-cell lymphoma

References

• Nogai H, Dorken B, Lenz G. Pathogenesis of non-Hodgkin lymphoma. J Clin Oncol. 2011;29:1803–1811.
   PubMed Web of Science ®Google Scholar
• Lossos IS. Molecular pathogenesis of diffuse large B-cell lymphoma. J Clin Oncol. 2005;23:6351–6357.
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937–1947.
   PubMed Web of Science ®Google Scholar
• Cultrera JL, Dalia SM. Diffuse large B-cell lymphoma: current strategies and future directions. Cancer Control. 2012;19:204–213.
   PubMed Web of Science ®Google Scholar
• Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol. 2014;11:12–23.
   PubMed Web of Science ®Google Scholar
• Gururajan M, Dasu T, Shahidain S, et al. Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth. J Immunol. 2007;178:111–121.
   PubMed Web of Science ®Google Scholar
• Maxwell SA, Mousavi-Fard S. Non-Hodgkin B-cell lymphoma: advances in molecular strategies targeting drug resistance. Exp Biol Med (Maywood). 2013;238:971–990.
   PubMed Web of Science ®Google Scholar
• Hachem A, Gartenhaus RB. Oncogenes as molecular targets in lymphoma. Blood. 2005;106:1911–1923.
   PubMed Web of Science ®Google Scholar
• Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood. 2003;101:1220–1235.
   PubMed Web of Science ®Google Scholar
• Leoncini L, Lazzi S, Bellan C, et al. Cell kinetics and cell cycle regulation in lymphomas. J Clin Pathol. 2002;55:648–655.
   PubMed Web of Science ®Google Scholar
• Zipori D, Barda-Saad M. Role of activin A in negative regulation of normal and tumor B lymphocytes. J Leukoc Biol. 2001;69:867–873.
   PubMed Web of Science ®Google Scholar
• Heinz M, Niederleithner HL, Puujalka E, et al. Activin A is anti-lymphangiogenic in a melanoma mouse model. J Invest Dermatol. 2015;135:212–221.
   PubMed Web of Science ®Google Scholar
• Seder CW, Hartojo W, Lin L, et al. INHBA overexpression promotes cell proliferation and may be epigenetically regulated in esophageal adenocarcinoma. J Thorac Oncol. 2009;4:455–462.
   PubMed Web of Science ®Google Scholar
• Seder CW, Hartojo W, Lin L, et al. Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. Neoplasia. 2009;11:388–396.
   PubMed Web of Science ®Google Scholar
• Wildi S, Kleeff J, Maruyama H, et al. Overexpression of activin A in stage IV colorectal cancer. Gut. 2001;49:409–417.
   PubMed Web of Science ®Google Scholar
• Okano M, Yamamoto H, Ohkuma H, et al. Significance of INHBA expression in human colorectal cancer. Oncol Rep. 2013;30:2903–2908
   PubMed Web of Science ®Google Scholar
• Kleeff J, Ishiwata T, Friess H, et al. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer. Int J Cancer. 1998;77:860–868.
   PubMed Web of Science ®Google Scholar
• Hofland J, van Weerden WM, Steenbergen J, et al. Activin A stimulates AKR1C3 expression and growth in human prostate cancer. Endocrinology. 2012;153:5726–5734.
   PubMed Web of Science ®Google Scholar
• Lee HY, Li CC, Huang CN, et al. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract. J Surg Oncol. 2014;111:414–422.
   PubMed Web of Science ®Google Scholar
• Matzuk MM, Finegold MJ, Su JG, et al. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 1992;360:313–319.
   PubMed Web of Science ®Google Scholar
• Matzuk MM, Finegold MJ, Mather JP, et al. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA. 1994;91:8817–8821.
   PubMed Web of Science ®Google Scholar
• Burdette JE, Jeruss JS, Kurley SJ, et al. Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. Cancer Res. 2005;65:7968–7975.
   PubMed Web of Science ®Google Scholar
• Kaneda H, Arao T, Matsumoto K, et al. Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer. Br J Cancer. 2011;105:1210–1217.
   PubMed Web of Science ®Google Scholar
• Panopoulou E, Murphy C, Rasmussen H, et al. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms. Cancer Res. 2005;65:1877–1886.
   PubMed Web of Science ®Google Scholar
• Xu Y, Jiang L, Fang J, et al. Loss of IRF8 inhibits the growth of diffuse large B-cell lymphoma. J Cancer. 2015;6:953–961.
   PubMed Web of Science ®Google Scholar
• Jiang L, Xu Y, Zeng X, et al. Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma. Oncotarget. 2015;6:31191–31202.
   PubMed Web of Science ®Google Scholar
• Visco C, Li Y, Xu-Monette ZY, et al. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia. 2012;26:2103–2113.
   PubMed Web of Science ®Google Scholar
• Xia Y, Schneyer AL. The biology of activin: recent advances in structure, regulation and function. J Endocrinol. 2009;202:1–12.
   PubMed Web of Science ®Google Scholar
• Antsiferova M, Werner S. The bright and the dark sides of activin in wound healing and cancer. J Cell Sci. 2012;125:3929–3937.
   PubMed Web of Science ®Google Scholar
• Pauklin S, Vallier L. Activin/nodal signalling in stem cells. Development. 2015;142:607–619.
   PubMed Web of Science ®Google Scholar
• Schramm A, von Schuetz V, Christiansen H, et al. High activin A-expression in human neuroblastoma: suppression of malignant potential and correlation with favourable clinical outcome. Oncogene. 2005;24:680–687.
   PubMed Web of Science ®Google Scholar
• Massague J. TGFbeta in cancer. Cell. 2008;134:215–230.
   PubMed Web of Science ®Google Scholar
• Brunelle JK, Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci. 2009;122:437–441.
   PubMed Web of Science ®Google Scholar
• Crow MT, Mani K, Nam YJ, et al. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res. 2004;95:957–970.
   PubMed Web of Science ®Google Scholar
• Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001;292:727–730.
   PubMed Web of Science ®Google Scholar
• Hutt KJ. The role of BH3-only proteins in apoptosis within the ovary. Reproduction. 2015;149:R81–R89.
   PubMed Web of Science ®Google Scholar
• Zauberman A, Oren M, Zipori D. Involvement of p21(WAF1/Cip1), CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition. Oncogene. 1997;15:1705–1711.
   PubMed Web of Science ®Google Scholar
• Macleod KF, Sherry N, Hannon G, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 1995;9:935–944.
   PubMed Web of Science ®Google Scholar
• Isaacs JS, Chiao C, Merrick BA, et al. p53-dependent p21 induction following gamma-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line. Cancer Res. 1997;57:2986–2992.
   PubMed Web of Science ®Google Scholar
• Xu H, Wang Z, Jin S, et al. Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression. Biochem Biophys Res Commun. 2014;446:235–240.
   PubMed Web of Science ®Google Scholar
• Cao Z, Ding BS, Guo P, et al. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell. 2014;25:350–365.
   PubMed Web of Science ®Google Scholar
• Young KH, Leroy K, Moller MB, et al. Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood. 2008;112:3088–3098.
   PubMed Web of Science ®Google Scholar